Travere Therapeutics (TVTX) Interest Coverage Ratio Growth (5y) (2018 - 2026)
Travere Therapeutics (TVTX) Interest Coverage Ratio Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - |
| 4 | BeOne Medicines | 471.51 Bn | 466.72 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.53% |
| Dec 31, 2025 | -22.31% |
| Sep 30, 2025 | 22.90% |
| Jun 30, 2025 | 35.89% |
| Mar 31, 2025 | -11.00% |
| Dec 31, 2024 | -99.14% |
| Sep 30, 2024 | -0.09% |
| Jun 30, 2024 | -2.78% |
| Mar 31, 2024 | -39.79% |
| Dec 31, 2023 | -58.83% |
| Sep 30, 2023 | 3.63% |
| Dec 31, 2022 | -55.11% |
| Sep 30, 2022 | -181.85% |
| Jun 30, 2022 | -128.77% |
| Mar 31, 2022 | -121.26% |
| Dec 31, 2021 | -57.35% |
| Sep 30, 2021 | -113.62% |
| Jun 30, 2021 | -79.19% |
| Mar 31, 2021 | -71.00% |
| Dec 31, 2020 | 25.27% |